VoxCell BioInnovation

VoxCell BioInnovation makes vascularized cancer tissue models for the drug development industry and oncology research
2020
26
Victoria, Canada

Innovation

Industry Problem

Complex biological structures are difficult to create

R&D Focus

3D bioprinting

Innovative Solution

Voxcell creates complex 3D printed models, bio-inks, and a high-resolution bioprinter specifically in the area of tissue engineering and the drug development industry

Solution Effectiveness

Voxcell aim to increase the accuracy between lab data and clinical trials, decreasing the time and costs related to drug development processes. Furthermore, their tissue printing technology can reduce the number of animal models used during drug testing

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$1.7M

Last Funding Date

Jan 1, 2023

Startup Stage

Early-Stage

Lead Investors

Creative Destruction Lab, Adara Ventures, Archangel Network of Funds, Boost Capital, Cindicates

People

Founders

CEO

Products

Product

Bioinks

Demo Product or Complete Product?

Complete Product

Future Plan

Investment Funding

VoxCell is in the process of raising $1M USD throughout July, 2022

Awards and Recognitions

Awards

Collision’s last-ever PITCH competition in Toronto 2024

Media Apperance

Douglas Magazine